Satellos Bioscience Valuation
| MSCLF Stock | USD 0.53 0.05 10.42% |
Satellos Bioscience is overvalued. Satellos Bioscience has a current Real Value of $0.46 per share. The regular price of the company is $0.53. Our model measures the value of Satellos Bioscience from inspecting the company fundamentals such as Return On Equity of -0.86, shares owned by institutions of 14.41 %, and Shares Outstanding of 41.8 M as well as reviewing its technical indicators and probability of bankruptcy. . In general, most investors recommend locking in undervalued stocks and disposing overvalued stocks since, at some point, asset prices and their ongoing real values will draw towards each other.
Overvalued
Today
Please note that Satellos Bioscience's price fluctuation is abnormally volatile at this time. Calculation of the real value of Satellos Bioscience is based on 3 months time horizon. Increasing Satellos Bioscience's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Satellos otc stock is determined by what a typical buyer is willing to pay for full or partial control of Satellos Bioscience. Since Satellos Bioscience is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Satellos OTC Stock. However, Satellos Bioscience's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.53 | Real 0.46 | Hype 0.57 | Naive 0.55 |
The real value of Satellos OTC Stock, also known as its intrinsic value, is the underlying worth of Satellos Bioscience OTC Stock, which is reflected in its stock price. It is based on Satellos Bioscience's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Satellos Bioscience's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Satellos Bioscience helps investors to forecast how Satellos otc stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Satellos Bioscience more accurately as focusing exclusively on Satellos Bioscience's fundamentals will not take into account other important factors: Satellos Bioscience Total Value Analysis
Satellos Bioscience is now expected to have takeover price of 7.17 M with market capitalization of 15.29 M, debt of , and cash on hands of 1.93 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Satellos Bioscience fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
7.17 M | 15.29 M | 1.93 M |
Satellos Bioscience Asset Utilization
One of the ways to look at asset utilization of Satellos is to check how much profit was generated for every dollar of assets it reports. Satellos Bioscience has a negative utilization of assets of -0.4 %, losing $0.003953 for each dollar of assets held by the company. Inadequate asset utilization indicates the company is being less effective with each dollar of assets it has. In other words, asset utilization of Satellos Bioscience shows how discouraging it operates for each dollar spent on its assets.Satellos Bioscience Ownership Allocation
Satellos Bioscience shows a total of 41.8 Million outstanding shares. Satellos Bioscience has 9.3 % of its outstanding shares held by insiders and 14.41 % owned by institutional holders. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.Satellos Bioscience Profitability Analysis
Net Loss for the year was (15.51 M) with loss before overhead, payroll, taxes, and interest of (793.97 K).Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Satellos Bioscience's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Satellos Bioscience and how it compares across the competition.
About Satellos Bioscience Valuation
The otc valuation mechanism determines Satellos Bioscience's current worth on a weekly basis. Our valuation model uses a comparative analysis of Satellos Bioscience. We calculate exposure to Satellos Bioscience's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Satellos Bioscience's related companies.Satellos Bioscience Inc., a regenerative medicine company, develops therapeutics to treat degenerative muscle diseases. The company was incorporated in 2012 and is headquartered in Toronto, Canada. Satellos Bioscience operates under Biotechnology classification in the United States and is traded on OTC Exchange.
8 Steps to conduct Satellos Bioscience's Valuation Analysis
OTC Stock's valuation is the process of determining the worth of any otc stock in monetary terms. It estimates Satellos Bioscience's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of otc stock valuation is a single number representing a OTC Stock's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Satellos Bioscience's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Satellos Bioscience's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Satellos Bioscience's revenue streams: Identify Satellos Bioscience's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Satellos Bioscience's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Satellos Bioscience's growth potential: Evaluate Satellos Bioscience's management, business model, and growth potential.
- Determine Satellos Bioscience's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the OTC Stock's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Satellos Bioscience's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Satellos Bioscience Growth Indicators
Investing in growth stocks can be very risky. If the company such as Satellos Bioscience does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 33 M | |
| Retained Earnings | -20.3 M |
Complementary Tools for Satellos OTC Stock analysis
When running Satellos Bioscience's price analysis, check to measure Satellos Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Satellos Bioscience is operating at the current time. Most of Satellos Bioscience's value examination focuses on studying past and present price action to predict the probability of Satellos Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Satellos Bioscience's price. Additionally, you may evaluate how the addition of Satellos Bioscience to your portfolios can decrease your overall portfolio volatility.
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Stocks Directory Find actively traded stocks across global markets | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |